AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2019
Apr 1, 2019
31676_dirs_2019-04-01_31acfefc-6ed6-4af7-b8ea-2cd9909822b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2019-03-28
Reporting Person: PRZYBYL ARTHUR (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-28 | Common Stock | A | 37280 | — | Acquired | 242356 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-28 | Stock Options | $66.39 | A | 45106 | Acquired | 2029-03-27 | Common Stock (45106) | Direct |
Footnotes
F1: The restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of March 28, 2019.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3